FAM217A
Protein FAM217A
Also known as: C6orf146, F217A_HUMAN, MGC43581
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IXS0
- Gene
- FAM217A
- Ensembl
- ENSG00000145975
- Chromosome
- 6
- Canonical length
- 508 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
No narrative summary is available for FAM217A in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
508 residues, UniProt reviewed canonical sequence.
>Q8IXS0|FAM217A
1 MGRRNENCAN SLRVSNISQE NLSHWNLDSE VPVSENKNLP AGRDGAAGGK INKNYLEIPV
61 EQLMLEPNLS VHSQKSTQNS KQGIFQLWNC PLNEGSTIEK REFKKSSVET GFNVINHPIR
121 VFTLNHPLTI ASVDKQVGPY PGLPMPLGLC WPYADGDFFK NRNEIHVSSC STIENNDGET
181 LPAPNWNLKH GNSSVEENFT DESDLSENEK TNDTLLSYFK KVDLNLKPET IKNVEEPFTE
241 EPNEVFPYPD FLPPPFSALD LHNLALSKSD NWKVTVDPAE TSVEHLITRL LELERLQHMT
301 IQKERPRLQT TFCTPAVTER PSSSKATPKV RQPKLCDSLS LQIPCVDKSQ EKSKNNSGSC
361 KLEQNALKRN WSNAGKYRWN SRPLSLKSSS TPKQLIETYD KNPKSSILSP CQELSFKPTI
421 GHTNQSMVKM VSTRCLPWRS PMPVSPIPLT FPENQKEEIK APKRNFGTKK KLYRQNIVLN
481 RPFSIQKLNC LSPSLIAKDK CCSPIEQKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FAM217A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.7
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- testis: 14 nTPM
- pancreas: 1.5 nTPM
- epididymis: 0.5 nTPM
- kidney: 0.3 nTPM
- cervix: 0.1 nTPM
- gallbladder: 0.1 nTPM
Single-cell type
- late spermatids: 704 nCPM
- cardiomyocytes: 218 nCPM
- early spermatids: 214 nCPM
- late primary spermatocytes: 206 nCPM
- epicardial cells: 196 nCPM
- adipocytes: 72 nCPM
Immune cell
- gdT-cell: 0.1 nTPM
- memory B-cell: 0.1 nTPM
- naive CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- cerebral cortex: 0.2 nTPM
- amygdala: 0.1 nTPM
- basal ganglia: 0.1 nTPM
- cerebellum: 0.1 nTPM
- midbrain: 0.1 nTPM
- pons: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.09
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.01
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FAM217A as an antibody target. Whether an autoantibody or antibody against FAM217A could matter depends on whether native FAM217A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FAM217A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FAM217A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...